Malignant epithelioid angiomyolipoma in the kidney and liver of a patient with pulmonary lymphangioleiomyomatosis: lack of response to sirolimus.
暂无分享,去创建一个
S. Yara | F. Higa | M. Tateyama | J. Fujita | K. Seyama | T. Kumasaka | S. Haranaga | M. Shiraishi | Y. Oshiro | T. Uchihara
[1] P. Crino,et al. The tuberous sclerosis complex. , 2006, The New England journal of medicine.
[2] Erick M Remer,et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. , 2008, The Journal of urology.
[3] Vincent J Schmithorst,et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. , 2008, The New England journal of medicine.
[4] F. Elmslie,et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. , 2008, The New England journal of medicine.
[5] A. Folpe,et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. , 2007, Human pathology.
[6] W. Kim,et al. Protein expression and mutational analysis of epidermal growth factor receptor in renal angiomyolipomas , 2007, Pathology international.
[7] H. L. Kim,et al. Clinical presentation of epithelioid angiomyolipoma , 2007, International journal of urology : official journal of the Japanese Urological Association.
[8] M. Kaplan,et al. Renal angiomyolipoma with malignant transformation, simultaneous occurrence with malignity and other complex clinical situations , 2007, International Urology and Nephrology.
[9] D. Brancaccio,et al. Molecular Pathogenesis of Genetic and Inherited Diseases Isolation and Growth of Smooth Muscle-Like Cells Derived from Tuberous Sclerosis Complex-2 Human Renal Angiomyolipoma Epidermal Growth Factor Is the Required Growth Factor , 2005 .
[10] C. Aul,et al. Antiangiogenetische Therapie eines Nieren-Angiomyolipoms bei einer schwerstbehinderten Patientin mit Multipler Sklerose , 2005 .
[11] C. Aul,et al. [Anti-angiogenic therapy of a renal angiomyolipoma in a seriously disabled patient suffering from multiple sclerosis]. , 2005, Aktuelle Urologie.
[12] E. Henske,et al. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[13] M. Benghanem,et al. Renal manifestations of tuberous sclerosis complex. , 2003, Annales de medecine interne.
[14] Tadashi Suzuki,et al. Malignant transformation of renal angiomyolipoma , 2003, International journal of urology : official journal of the Japanese Urological Association.
[15] Hongbing Zhang,et al. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma , 2003, The Lancet.
[16] J. Boelaert,et al. Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] Tsuyoshi Saito,et al. Malignant Transformation of Renal Angiomyolipoma: A Case Report , 2002, The American journal of surgical pathology.
[18] A. Gown,et al. Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. , 2001, Archives of pathology & laboratory medicine.
[19] G. Zamboni,et al. Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions. , 2000, The American journal of surgical pathology.
[20] E. Henske,et al. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.